Articles dans des revues avec comité de lecture (46)
  1. 13. Merimi, M., Buyl, K., Daassi, D., Rodrigues, R. M., Melki, R., Lewalle, P., Vanhaecke, T., Fahmi, H., Rogiers, V., Lagneaux, L., De Kock, J., & Najar, M. (2021). Transcriptional profile of cytokines, regulatory mediators and tlr in mesenchymal stromal cells after inflammatory signaling and cell-passaging. International journal of molecular sciences, 22(14), 7309. doi:10.3390/ijms22147309
  2. 14. Merimi, M., Lewalle, P., Meuleman, N., Agha, D. M., El-Kehdy, H., Bouhtit, F., Ayoub, S., Burny, A., Fahmi, H., Lagneaux, L., & Najar, M. (2021). Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic. Journal of Clinical Medicine, 10(5). doi:10.3390/jcm10050905
  3. 15. Merimi, M., Lagneaux, L., Lombard, C. A., Moussa Agha, D., Bron, D., Lewalle, P., Meuleman, N., Najimi, M., Sokal, E. M., & Najar, M. (2021). Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules. Inflammation research. doi:10.1007/s00011-020-01428-9
  4. 16. Bouhtit, F., Najar, M., Moussa Agha, D., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Bron, D., Meuleman, N., Hamal, A., Lagneaux, L., Lewalle, P., & Merimi, M. (2021). New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways. Molecules (Print Archive Edition), 26(2), 410. doi:10.3390/molecules26020410
  5. 17. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Fayyad Kazan, H., Lagneaux, L., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction. Cells, 9(9). doi:10.3390/cells9092053
  6. 18. El-Kehdy, H., Najar, M., De Kock, J., Moussa Agha, D., Rogiers, V., Merimi, M., Lagneaux, L., Sokal, E. M., & Najimi, M. (2020). Inflammation Differentially Modulates the Biological Features of Adult Derived Human Liver Stem/Progenitor Cells. Cells, 9(7). doi:10.3390/cells9071640
  7. 19. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Naamane, N., Fayyad Kazan, H., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. International journal of molecular sciences, 21(19). doi:10.3390/ijms21197065
  8. 20. Buyl, K., Merimi, M., Rodrigues, R. M., Moussa Agha, D., Melki, R., Vanhaecke, T., Bron, D., Lewalle, P., Meuleman, N., Fahmi, H., Rogiers, V., Lagneaux, L., Kock, J. D., & Najar, M. (2020). The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells. Journal of Clinical Medicine, 9(3), 696. doi:10.3390/jcm9030696
  9. 21. De Kock, J., Rodrigues, R. M., Branson, S., Verhoye, L., Colemonts-Vroninks, H., Rombaut, M., Boeckmans, J., Neuckermans, J., Lequeue, S., Buyl, K., Merimi, M., Moussa Agha, D., De Boe, V., Lagneaux, L., Meuleman, P., Vanhaecke, T., & Najar, M. (2020). Inflammation Alters the Secretome and Immunomodulatory Properties of Human Skin-Derived Precursor Cells. Cells, 9(4). doi:10.3390/cells9040914
  10. 22. Merimi, M., Lagneaux, L., Moussa Agha, D., Lewalle, P., Meuleman, N., Burny, A., Fahmi, H., & Najar, M. (2020). Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use. Journal of Clinical Medicine, 9(5). doi:10.3390/jcm9051516
  11. 23. Bouhtit, F., Najar, M., Moussa Agha, D., Melki, R., Najimi, M., Sadki, K., Lewalle, P., Hamal, A., Lagneaux, L., & Merimi, M. (2019). The biological response of mesenchymal stromal cells to thymol and carvacrol in comparison to their essential oil: An innovative new study. Food and chemical toxicology, 134, 110844. doi:10.1016/j.fct.2019.110844
  12. 24. Najar, M., Bouhtit, F., Melki, R., Afif, H., Hamal, A., Fahmi, H., Merimi, M., & Lagneaux, L. (2019). Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges. Journal of Clinical Medicine, 8(5), 626. doi:10.3390/jcm8050626
    13. << Précédent 1 2 3 4 5 Suivant >>